Squarepoint Ops »

Taysha Gene Therapies shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2024-06-30 $180k 80k 2.24
2024-03-31 $614k 214k 2.87
2023-12-31 $112k 64k 1.77
2023-09-30 $90k 29k 3.16
2023-06-30 $53k 81k 0.66
2021-12-31 $340k 29k 11.64

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Eafe Etf Put Option (EFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Microsoft Corporation Put Option (MSFT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Msci Brazil Etf Call Option (EWZ)
Tesla Motors Call Option (TSLA)
Pdd Holdings Sponsored Ads Call Option (PDD)

View all positions for Squarepoint Ops

Top funds holding Taysha Gene Therapies

BlackRock
RA Capital Management
VR Adviser
Siren
Octagon Capital Advisors
Baker Bros. Advisors
Geode Capital Management
Jpmorgan Chase & Co
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust
Woodline Partners
Schonfeld Strategic Advisors
Palo Alto Investors
Quantum Private Wealth

View all funds holding Taysha Gene Therapies